Event Home
FDA Updates With Agency Leadership: Removing Black Box Warnings for HRT Part 1
‘Learn more about why the FDA is initiating label changes for hormone replacement therapy products for menopausal women.’
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.
